Literature DB >> 19728742

2.6 A X-ray crystal structure of human p53R2, a p53-inducible ribonucleotide reductase .

Peter Smith1, Bingsen Zhou, Nam Ho, Yate-Ching Yuan, Leila Su, Shiou-Chuan Tsai, Yun Yen.   

Abstract

Human p53R2 (hp53R2) is a 351-residue p53-inducible ribonucleotide reductase (RNR) small subunit. It shares >80% sequence identity with hRRM2, the small RNR subunit responsible for normal maintenance of the deoxyribonucleotide (dNTP) pool used for DNA replication, which is active during the S phase in a cell cycle-dependent fashion. But rather than cyclic dNTP synthesis, hp53R2 has been shown to supply dNTPs for DNA repair to cells in G0-G1 in a p53-dependent fashion. The first X-ray crystal structure of hp53R2 is determined to 2.6 A, in which monomers A and B exhibit mono- and binuclear iron occupancy, respectively. The pronounced structural differences at three regions between hp53R2 and hRRM2 highlight the possible regulatory role in iron assimilation and help explain previously observed physical and biochemical differences in the mobility and accessibility of the radical iron center, as well as radical transfer pathways between the two enzymes. The sequence-structure-function correlations that differentiate hp53R2 and hRRM2 are revealed for the first time. Insight gained from this structural work will be used in the identification of biological function, regulation mechanism, and inhibitor selection in RNR small subunits.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728742      PMCID: PMC2844085          DOI: 10.1021/bi9001425

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Rapid automated molecular replacement by evolutionary search.

Authors:  C R Kissinger; D K Gehlhaar; D B Fogel
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-02

2.  p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.

Authors:  T Yamaguchi; K Matsuda; Y Sagiya; M Iwadate; M A Fujino; Y Nakamura; H Arakawa
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

3.  S Phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region.

Authors:  Anna Lena Chabes; Stefan Björklund; Lars Thelander
Journal:  J Biol Chem       Date:  2003-12-19       Impact factor: 5.157

4.  In vitro characterization of enzymatic properties and inhibition of the p53R2 subunit of human ribonucleotide reductase.

Authors:  Jimin Shao; Bingsen Zhou; Lijun Zhu; Weihua Qiu; Yate-Ching Yuan; Bixin Xi; Yun Yen
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

5.  Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks.

Authors:  A Chabes; L Thelander
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

6.  A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.

Authors:  H Tanaka; H Arakawa; T Yamaguchi; K Shiraishi; S Fukuda; K Matsui; Y Takei; Y Nakamura
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

7.  Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells.

Authors:  O Guittet; P Håkansson; N Voevodskaya; S Fridd; A Gräslund; H Arakawa; Y Nakamura; L Thelander
Journal:  J Biol Chem       Date:  2001-08-21       Impact factor: 5.157

Review 8.  Di-iron-tyrosyl radical ribonucleotide reductases.

Authors:  JoAnne Stubbe
Journal:  Curr Opin Chem Biol       Date:  2003-04       Impact factor: 8.822

9.  Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools.

Authors:  Takashi Kimura; Satoshi Takeda; Yoji Sagiya; Mitsukazu Gotoh; Yusuke Nakamura; Hirofumi Arakawa
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

10.  Nuclear factor Y regulation and promoter transactivation of human ribonucleotide reductase subunit M2 gene in a Gemcitabine resistant KB clone.

Authors:  Xiyong Liu; Bingsen Zhou; Lijun Xue; Weihua Qiu; Jennifer Shih; Shu Zheng; Yun Yen
Journal:  Biochem Pharmacol       Date:  2004-04-15       Impact factor: 5.858

View more
  19 in total

1.  Proton Coupled Electron Transfer and Redox Active Tyrosines: Structure and Function of the Tyrosyl Radicals in Ribonucleotide Reductase and Photosystem II.

Authors:  Bridgette A Barry; Jun Chen; James Keough; David Jenson; Adam Offenbacher; Cynthia Pagba
Journal:  J Phys Chem Lett       Date:  2012-02-08       Impact factor: 6.475

2.  Caspase-dependent Proteolysis of Human Ribonucleotide Reductase Small Subunits R2 and p53R2 during Apoptosis.

Authors:  Ali Tebbi; Olivier Guittet; Karine Tuphile; Aimeric Cabrié; Michel Lepoivre
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

Review 3.  Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures.

Authors:  Simona Carnio; Silvia Novello; Mauro Papotti; Marco Loiacono; Giorgio Vittorio Scagliotti
Journal:  Transl Lung Cancer Res       Date:  2013-10

4.  Structural basis on the dityrosyl-diiron radical cluster and the functional differences of human ribonucleotide reductase small subunits hp53R2 and hRRM2.

Authors:  Bingsen Zhou; Leila Su; Yate-Ching Yuan; Frank Un; Norby Wang; Madhukar Patel; Bixin Xi; Shuya Hu; Yun Yen
Journal:  Mol Cancer Ther       Date:  2010-05-18       Impact factor: 6.261

Review 5.  Protein design: toward functional metalloenzymes.

Authors:  Fangting Yu; Virginia M Cangelosi; Melissa L Zastrow; Matteo Tegoni; Jefferson S Plegaria; Alison G Tebo; Catherine S Mocny; Leela Ruckthong; Hira Qayyum; Vincent L Pecoraro
Journal:  Chem Rev       Date:  2014-03-24       Impact factor: 60.622

6.  Understanding the molecular interactions of different radical scavengers with ribonucleotide reductase M2 (hRRM2) domain: opening the gates and gaining access.

Authors:  Arijit Basu; Barij N Sinha
Journal:  J Comput Aided Mol Des       Date:  2012-05-26       Impact factor: 3.686

7.  Expression, purification, crystallization and preliminary X-ray analysis of ORF60, the small subunit (R2) of ribonucleotide reductase from Kaposi's sarcoma-associated herpesvirus (KSHV).

Authors:  Daniel Gurmu; Sue-Li Dahlroth; Juergen Haas; Pär Nordlund; Heidi Erlandsen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-05-29

Review 8.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

9.  HF-EPR, Raman, UV/VIS light spectroscopic, and DFT studies of the ribonucleotide reductase R2 tyrosyl radical from Epstein-Barr virus.

Authors:  Ane B Tomter; Giorgio Zoppellaro; Florian Schmitzberger; Niels H Andersen; Anne-Laure Barra; Henrik Engman; Pär Nordlund; K Kristoffer Andersson
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

10.  Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics.

Authors:  Robert D S Pitceathly; Conrad Smith; Carl Fratter; Charlotte L Alston; Langping He; Kate Craig; Emma L Blakely; Julie C Evans; John Taylor; Zarfishan Shabbir; Marcus Deschauer; Ute Pohl; Mark E Roberts; Matthew C Jackson; Christopher A Halfpenny; Peter D Turnpenny; Peter W Lunt; Michael G Hanna; Andrew M Schaefer; Robert McFarland; Rita Horvath; Patrick F Chinnery; Douglass M Turnbull; Joanna Poulton; Robert W Taylor; Gráinne S Gorman
Journal:  Brain       Date:  2012-10-29       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.